#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14538	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2350	616.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1585	1585	C	855	C	796	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26412	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3560	739.6	0	.	n	.	0	T695C	SNP	695	695	T	989	989	C	782	C,T	726,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26412	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3560	739.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1631	1631	A	840	A,G	788,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26412	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3560	739.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2265	2265	C	890	C,A	819,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26412	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3560	739.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2891	2891	T	765	T	728	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26412	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3560	739.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2339	2339	A	863	A	807	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	V36A	NONSYN	106	108	GTG	453	455	GCG	193;195;196	G;C;G	184;187;187	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	495	497	CGG	187;188;183	C;G;G	173;174;169	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	S68L	NONSYN	202	204	TCG	549	551	TTG	171;171;172	T,C;T,C;G,T	153,1;158,1;159,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	A90V	NONSYN	268	270	GCG	615	617	GTT	173;172;173	G;T,C;T,G	163;161,1;159,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	I105V	NONSYN	313	315	ATT	660	662	GTT	183;182;178	G;T;T	169;167;166	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	N125T	NONSYN	373	375	AAT	720	722	ACC	190;189;188	A;C;C	175;178;178	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	R135C	NONSYN	403	405	CGT	750	752	TGT	201;201;198	T;G;T	179;184;179	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	K151E	NONSYN	451	453	AAA	798	800	GAA	162;164;163	G;A,G;A	153;154,1;155	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	801	803	AAC	161;159;158	A;A;C	155;152;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	A172T	NONSYN	514	516	GCG	861	863	ACA	139;139;139	A;C;A	132;135;134	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	A175E	NONSYN	523	525	GCG	870	872	GAA	145;145;145	G;A;A	141;139;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	E176T	NONSYN	526	528	GAA	873	875	ACC	148;148;149	A;C;C	137;141;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	I178V	NONSYN	532	534	ATC	879	881	GTC	151;153;154	G;T;C	145;146;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	I188T	NONSYN	562	564	ATA	909	911	ACG	157;155;161	A;C;G	144;145;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	P200N	NONSYN	598	600	CCC	945	947	AAC	177;179;178	A;A;C	165;166;165	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1005	1007	TTG	189;190;188	T;T;G	167;170;167	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1062	1064	ACC	169;168;168	A;C;C	152;155;155	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1065	1067	GAC	168;169;170	G,A;A;C	153,1;150;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1074	1076	GCG	166;168;170	G;C;G	154;130;157	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1110	1112	GCT	149;149;148	G;C;T	136;140;135	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1770	folP	858	858	91.61	folP.l6.c4.ctg.1	1551	113.5	1	SNP	p	R230S	1	.	.	688	690	AGC	1035	1037	AGC	201;199;197	A;G;C	184;182;182	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5642	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3477	161.6	1	SNP	p	S91F	0	.	.	271	273	TCC	518	520	TCC	204;203;206	T;C;C	188;186;188	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5642	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3477	161.6	1	SNP	p	D95N	0	.	.	283	285	GAC	530	532	GAC	203;200;201	G;A;C	189;184;186	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5642	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3477	161.6	1	SNP	p	D95G	0	.	.	283	285	GAC	530	532	GAC	203;200;201	G;A;C	189;184;186	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1686	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1422	118.0	1	SNP	p	G45D	1	.	.	133	135	GAC	478	480	GAC	207;210;211	G;A;C	194;190;195	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	890	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1030	85.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5298	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	174.8	1	SNP	p	D86N	0	.	.	256	258	GAC	608	610	GAC	202;201;199	G;A;C	190;189;189	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5298	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	174.8	1	SNP	p	S87R	0	.	.	259	261	AGT	611	613	AGT	199;200;202	A;G;T	187;190;189	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5298	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	174.8	1	SNP	p	S87W	0	.	.	259	261	AGT	611	613	AGT	199;200;202	A;G;T	187;190;189	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5298	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	174.8	1	SNP	p	S87I	0	.	.	259	261	AGT	611	613	AGT	199;200;202	A;G;T	187;190;189	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5298	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3022	174.8	1	SNP	p	S88P	0	.	.	262	264	TCC	614	616	TCC	202;201;203	T;C;C	193;189;191	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4440	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2772	159.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1653	1655	GGC	224;221;219	G;G;C	205;200;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1307	1309	GCA	201;202;203	G,A;C;A,T	186,1;188;188,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1310	1312	ATC	207;207;207	A;T;C	189;192;192	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1322	1324	GTG	200;198;200	G;T;G	187;184;186	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1322	1324	GTG	200;198;200	G;T;G	187;184;186	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1826	1828	ACC	202;202;204	A;C;C	184;187;187	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1880	1882	GCG	183;183;180	G;C;G	159;145;146	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1880	1882	GCG	183;183;180	G;C;G	159;145;146	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2003	2005	GGC	140;141;139	G;G;C	125;127;125	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2012	2014	GGC	134;132;131	G;G;C	120;123;123	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3822	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2580	147.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2030	2032	CCG	124;122;124	C,G;C;G	95,2;91;94	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5816	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3080	187.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1574	1576	CTG	186;187;187	C;T;G	167;169;175	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2556	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1661	152.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	513	513	C	206	C	189	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	G38E	NONSYN	112	114	GGA	451	453	GAA	241;244;241	G;A;A	222;227;225	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	481	483	GGA	249;251;252	G;G,A;A	235;234,1;233	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	T87A	NONSYN	259	261	ACT	598	600	GCT	223;224;227	G;C;T	203;206;206	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	604	606	AGC	219;219;219	A;G;C	200;202;204	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	696	697	CG	218;220	C;G	202;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	699	701	CAG	220;214;213	C;A;G	199;194;194	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	703	705	AAA	213;212;212	A;A;A	194;196;194	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	766	768	GAA	209;207;207	G,C;A;A	187,1;188;186	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	790	792	GCA	210;212;214	G;C,T;A	194;191,1;191	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	N212D	NONSYN	634	636	AAT	973	975	GAT	201;201;201	G;A;T	194;195;190	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	D213G	NONSYN	637	639	GAT	976	978	GGT	199;200;198	G;G;T	188;190;189	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	I218M	NONSYN	652	654	ATA	991	993	ATG	209;209;208	A;T;G	198;200;199	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1105	1107	GCA	196;197;195	G;C;A	180;181;180	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1108	1110	ACG	193;194;198	A;C;G	179;178;183	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1111	1113	GGG	196;198;199	G;G;G	179;183;179	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1114	1116	GTT	198;200;204	G;T;T	180;183;187	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1174	1176	GTA	215;211;212	G;T;A	200;196;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1213	1215	ACT	230;232;232	A;C;T	207;209;209	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1219	1221	GAT	227;229;234	G;A;T	205;207;212	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1231	1233	CAC	235;231;231	C;A;C	211;209;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	1	SNP	p	G120K	1	.	.	358	360	AAG	696	698	CGG	218;220;215	C;G;G	202;203;197	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	1	SNP	p	D121N	0	.	.	361	363	GAC	699	702	CGC	220;213;213	C;G;C	199;194;196	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2696	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1529	175.2	1	SNP	p	A121D	1	.	.	361	363	GAC	699	702	CGC	220;213;213	C;G;C	199;194;196	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9922	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	5070	195.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2143	2145	CAT	222;220;217	C;A;T	203;203;200	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1108	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1078	102.2	1	SNP	p	V57M	1	.	.	169	171	ATG	483	485	ATG	232;229;229	A;T;G	218;215;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
